Novavax
NVAX
#5457
Rank
ยฃ1.13 B
Marketcap
ยฃ6.90
Share price
-3.89%
Change (1 day)
47.58%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of March 2026 : ยฃ0.22 Billion

According to Novavax's latest financial reports the company's total debt is ยฃ0.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ0.18 B0.62%
2024-12-31ยฃ0.18 B2.11%
2023-12-31ยฃ0.17 B-60.43%
2022-12-31ยฃ0.45 B35.12%
2021-12-31ยฃ0.33 B-2.04%
2020-12-31ยฃ0.34 B39.87%
2019-12-31ยฃ0.24 B-2.38%
2018-12-31ยฃ0.25 B6.95%
2017-12-31ยฃ0.23 B-8.29%
2016-12-31ยฃ0.25 B96083.1%
2015-12-31ยฃ0.26 M-58.42%
2014-12-31ยฃ0.64 M-43.79%
2013-12-31ยฃ1.14 M52.96%
2012-12-31ยฃ0.74 M262.12%
2011-12-31ยฃ0.2 M-20.54%
2010-12-31ยฃ0.25 M-13.72%
2009-12-31ยฃ0.3 M-98.08%
2008-12-31ยฃ15.63 M36.5%
2007-12-31ยฃ11.45 M-3.27%
2006-12-31ยฃ11.83 M-33.13%
2005-12-31ยฃ17.7 M-8.54%
2004-12-31ยฃ19.35 M-17.87%
2003-12-31ยฃ23.57 M-8.72%
2002-12-31ยฃ25.82 M9.04%
2001-12-31ยฃ23.68 M76.73%
2000-12-31ยฃ13.4 M21552.36%
1999-12-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
ยฃ35.51 B 15,828.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ48.15 B 21,499.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ25.62 B 11,395.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ19.06 B 8,453.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
ยฃ0.78 B 251.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.44 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ34.58 M-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
ยฃ1.13 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.61 B 177.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.50 B 124.74%๐Ÿ‡บ๐Ÿ‡ธ USA